Vaccines 101 and Syntegon’s Fill-Finish Portfolio

In the midst of our current, ever-changing worldwide coronavirus crisis, the word on everyone’s mind is vaccine.  Never before have the world’s scientific and pharmaceutical communities felt such a collective rush to bring life-saving vaccines to market. In today’s post, our resident filling systems and single-use technology expert, Dr. Laura Moody, provides an overview of the different types of vaccines, how they work, and how Syntegon’s fill-finish portfolio supports clinical and commercial manufacturing.

 

The intention behind a vaccine is to train the body’s immune cells …More



Syntegon Delivers 16th and 17th Model FLT Small Batch Vial Filler for ATMPs

FLT #16 configured to fill gene therapy products in an isolator

 

The Minneapolis plant of Syntegon is proud to announce the delivery of its 16th and 17th model FLT small batch vial filler for ATMP applications. Configured to fill gene therapy products in an isolator and oncolytic immunotherapies and vaccines in a RABS, respectively, these latest deliveries of the proven FLT platform for RTU vials exemplify the trend towards smaller batches of higher value products and highlight Syntegon’s track record of providing solutions that meet the exacting requirements of the rapidly growing ATMP segment.

The Syntegon FLT vial filler is designed …More


Russian regulatory against counterfeiting of cosmetic products

By end of December 2019, the Russian government published regulatory guidelines regarding Track & Trace for cosmetic products. Aim is to inform and protect customers from counterfeits. Since the deadlines are quite close, we have set up all information regarding necessary activities and the ways of implementing in time. …More


ATMP small batch fillers done right, delivered fast

Get your ATMP filler delivered in 6 months.

The model FLT in a standard RABS configuration from Syntegon is available in six months or less. The Syntegon FLT vial filler is designed as a platform for clinical trial production and small batch manufacturing of high value pharmaceuticals. Combining Syntegon’s know-how and design experience in both vial filler and barrier system technologies, the FLT …More



Staying Connected to Syntegon’s North American Pharma Subject Matter Experts & Updated Trade Show Schedule due to COVID-19

Amid the challenging business environment due to COVID-19, our North America-based subject matter experts remain available on demand to assist customers and partners on their pharmaceutical packaging projects. We invite you to reach out to them directly for timely assistance. The next opportunities to meet in person at industry events will be, as things currently stand, according to our revised remaining trade show schedule for 2020 as indicated below. …More



ADCs & state-of-the-art fill-finish technology (for high potent drugs)

These days people are talking a lot about cell/gene therapy drugs, clinical trials, monoclonal antibodies and other exciting topics around small batch fill-finish solutions. Syntegon provides robust and sustainable solutions at an affordable price for every business size. There are solutions for clinical trials, small batch applications, and higher output rates.

There´s a growing demand for small batch production for ADC products (Antibody Drug Conjugates). The operator safety and the best possible protection for these types of drugs is crucial. Syntegon’s approach is …More



Top of page